Gellersen B, Kempf R, Telgmann R, DiMattia G E
Institute for Hormone and Fertility Research, University of Hamburg, Germany.
Mol Endocrinol. 1995 Jul;9(7):887-901. doi: 10.1210/mend.9.7.7476971.
We describe a human (h) PRL-producing cell line, SKUT-1B-20, which we isolated as a subclone of a uterine sarcoma cell line. Although this cell line is of uterine origin, it does not use the decidual-specific upstream promoter of the hPRL gene, but transcribes the hPRL gene from the downstream pituitary-type transcription start site, as determined by Northern blot, reverse transcriptase-polymerase chain reaction and primer extension analyses. This is particularly intriguing because SKUT-1B-20 cells lack the transcription factor Pit-1. No Pit-1 messenger RNA was detectable by reverse transcriptase-polymerase chain reaction, and endogenous Pit-1 target genes (GH, PRL, and Pit-1) were refractory to transfected Pit-1 expression vector, whereas in cotransfection experiments, Pit-1 efficiently activated reporter gene fusion constructs carrying 5'-flanking sequences of the human and rat PRL or the mouse Pit-1 genes. By transfecting reporter genes containing 8.7 kilobases of DNA flanking the hPRL pituitary-specific start site (hPRL-8700/Luc) and deletions thereof, we located a Pit-1-independent cis-active region more than 7 kilobases upstream of the start site. The most distal 1650 or 880 base pairs of the hPRL genomic fragment (which extends to -8784 base pairs), when placed directly upstream of the homologous hPRL or the heterologous thymidine kinase promoters, conferred transcriptional activation to those promoters. SKUT-1B-20 cell-specific activation of hPRL-8700/Luc could not be suppressed by the introduction of an inhibitor of protein kinase A (PKA), PKI. This is the first demonstration of pituitary-type PRL gene transcription independent of Pit-1 and activation of the PKA pathway. The SKUT-1B-20 cell line was then used in reconstitution experiments to delineate the role of Pit-1 in modulating the transcriptional effects of phorbol ester, PKA, and estrogen receptor (ER) on the hPRL gene. The low response of hPRL/luciferase fusion genes to phorbol ester was greatly enhanced by cotransfected Pit-1 and was mediated by the proximal region between -250 and -38. The catalytic subunit of PKA, C beta, was able to elicit a moderate induction of hPRL-8700/Luc even in the absence of Pit-1. A potential estrogen response element has been located in the hPRL gene sequence at a position similar to that of the estrogen response element of the rat PRL gene immediately adjacent to the distal enhancer.(ABSTRACT TRUNCATED AT 400 WORDS)
我们描述了一种产生人催乳素(hPRL)的细胞系SKUT-1B-20,它是从子宫肉瘤细胞系中分离出的一个亚克隆。尽管该细胞系起源于子宫,但它并不使用hPRL基因的蜕膜特异性上游启动子,而是从下游垂体型转录起始位点转录hPRL基因,这是通过Northern印迹、逆转录酶-聚合酶链反应及引物延伸分析确定的。这一点特别引人关注,因为SKUT-1B-20细胞缺乏转录因子Pit-1。通过逆转录酶-聚合酶链反应检测不到Pit-1信使核糖核酸,内源性Pit-1靶基因(生长激素、催乳素和Pit-1)对转染的Pit-1表达载体不敏感,而在共转染实验中,Pit-1能有效激活携带人及大鼠催乳素或小鼠Pit-1基因5'侧翼序列的报告基因融合构建体。通过转染含有hPRL垂体特异性起始位点侧翼8.7千碱基DNA的报告基因(hPRL-8700/Luc)及其缺失片段,我们在起始位点上游7千碱基以上定位了一个不依赖Pit-1的顺式作用活性区域。hPRL基因组片段最远端的1650或880碱基对(延伸至-8784碱基对),当直接置于同源hPRL或异源胸苷激酶启动子上游时,能赋予这些启动子转录激活能力。蛋白激酶A(PKA)抑制剂PKI的引入并不能抑制SKUT-1B-20细胞对hPRL-8700/Luc的特异性激活。这是首次证明垂体型PRL基因转录不依赖Pit-1且PKA途径被激活。然后将SKUT-1B-20细胞系用于重组实验以阐明Pit-1在调节佛波酯、PKA和雌激素受体(ER)对hPRL基因转录作用中的角色。共转染的Pit-1极大增强了hPRL/荧光素酶融合基因对佛波酯的低反应性,且这种增强由-250至-38之间的近端区域介导。即使在没有Pit-1的情况下,PKA的催化亚基Cβ也能引起hPRL-8700/Luc的适度诱导。在hPRL基因序列中已定位到一个潜在的雌激素反应元件,其位置与紧邻远端增强子的大鼠PRL基因雌激素反应元件位置相似。(摘要截短于400词)